Esperion Therapeutics Surpasses Q2 Expectations with Strong Financial Performance
Esperion Therapeutics reported strong Q2 financial results, exceeding earnings expectations and revenue forecasts, positioning the company for continued growth and success in the healthcare industry.
2 minutes to read